lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

3 rows where filing_uuid = "0780de4e-6d8e-40f4-9f17-eea2e9da7c0e" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: received_date (date)

issue_code 3

filing_year 1

filing_period 1

id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1840196 WILLIAMS AND JENSEN, PLLC 0780de4e-6d8e-40f4-9f17-eea2e9da7c0e Q2 WILLIAMS AND JENSEN, PLLC 41454 ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) 2016 second_quarter HCR 21st Century Cures Initiative (House Energy and Commerce Committee) and Innovations for Healthier Americans (Senate Health, Education, Labor and Pensions Committee); possible drug provisions in FY 2017 appropriations bills; Drug safety and drug counterfeiting; Drug importation; 340B Program; Authorized generics; Drug company patent settlements; Senate Finance Committee Chronic Disease Initiative; Implementation of Precision Medicine Initiative; White House Cancer Moonshot; Legislation affecting the ESRD program. HOUSE OF REPRESENTATIVES,SENATE,Vice President of the U.S. 50000   0 0 2016-07-12T14:09:09.073000-04:00
1840197 WILLIAMS AND JENSEN, PLLC 0780de4e-6d8e-40f4-9f17-eea2e9da7c0e Q2 WILLIAMS AND JENSEN, PLLC 41454 ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) 2016 second_quarter TAX Tax issues affecting the pharmaceutical industry, tax reform issues. HOUSE OF REPRESENTATIVES,SENATE,Vice President of the U.S. 50000   0 0 2016-07-12T14:09:09.073000-04:00
1840198 WILLIAMS AND JENSEN, PLLC 0780de4e-6d8e-40f4-9f17-eea2e9da7c0e Q2 WILLIAMS AND JENSEN, PLLC 41454 ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP) 2016 second_quarter MMM Medicare prescription drug benefit; Drug rebates for Medicare Part D; Part D benefit structure; Payment policies for Medicare Part B Prescription drugs; Independent Payment Advisory Board (IPAB). HOUSE OF REPRESENTATIVES,SENATE,Vice President of the U.S. 50000   0 0 2016-07-12T14:09:09.073000-04:00

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);